A jury awarded $27 million to a couple who alleged a spinal cord stimulator led to a man’s permanent spine injuries, Florida Today reported Dec. 18. The man was admitted to Holmes Regional Medical ...
J&J wins FDA approval for TRUFILL system to treat chronic subdural hematoma via middle meningeal artery embolization.
Johnson & Johnson MedTech announced that the FDA has approved an expanded indication for the company’s TruFill n-But ...
Medtronic (NYSE: MDT) and Johnson & Johnson (NYSE: JNJ) have both announced recent regulatory milestones for liquid embolic ...
Today, Johnson & Johnson MedTech, a leader in neurovascular care, announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for the TRUFILL n‑BCA Liquid Embolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results